NEW YORK (GenomeWeb News) - Agendia has acquired ISO/IEC 17025:2005 accreditation for its CupPrint microarray service from the Dutch Accreditation Council, the company said today.
 
The company was granted ISO 17025 accreditations for MammaPrint, a microarray-based breast cancer diagnostic, in Sept. 2005. According to Agendia, it is the first company to receive this accreditation for the test.
 
CupPrint is a test for cancer of unknown primary.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.